MODIS THERAPEUTICS
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
MODIS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Oakland, California, United States
Country:
United States
Website Url:
http://www.modistx.com
Total Employee:
11+
Status:
Active
Contact:
+1-510-806-8562
Email Addresses:
[email protected]
Total Funding:
30 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS AWS Global Accelerator
Similar Organizations
Active Therapy Systems
Active Therapy Systems develops an interactive exercise platform to deliver in-home therapies to people living with Parkinson's disease.
Aelin Therapeutics
Aelin Therapeutics is a provider of a biotherapeutics platform technology called pept-ins that are intended to harnesses.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Avrion Therapeutics
Avrion Therapeutics is a precision Gene Therapies for Neurodegenerative Diseases.
Biochip Labs
Biochip Labs provides blood disorder testing for conditions like sickle cell disease and thalassemia.
BrickBuilt Therapeutics
Microbiome-focused therapeutics for diseases of the oral cavity and their systemic effects
CoA Therapeutics
CoA Therapeutics develops novel therapies for difficult to treat and rare genetic disorders.
Coro Health
Coro Health is a provider of therapeutic music and spiritual support to individuals within various healthcare environments.
Creative BioTherapeutics
Creative BioTherapeutics discovers treatments for patients with incurable diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Discovery DX
Discovery DX (Discovery Diagnostics) will disrupt the market in Point-of-Care Testing (POCT) for infectious diseases.
Gravity Medical Technology
World-Class Endovascular Treatment Devices
HIVE Medical
HIVE Medical is transitioning to an outpatient environment to save money, but patients at home struggle with drug adherence.
Immundnz
Immundnz is a CRO specialised in immunology, immune modelling, tissue damage analysis.
Koligo therapeutics
Koligo therapeutics is a transformational cell therapies for patients with pancreatic disease .
Koutif Therapeutics
Koutif Therapeutics is advancing discoveries from researchers at the University of Pittsburgh.
Mendelian
Mendelian is helping doctors diagnose rare genetic diseases faster.
Mitoconix Bio
Mitoconix Bio is pioneering a disease-modifying strategy of improving mitochondrial functions for treating neurodegenerative diseases.
Nanocan Therapeutics
Nanocan Therapeutics provides medicines and other products intended to patients with certain cancers, respiratory tract infections.
Ocelot Bio
Ocelot Bio brings new treatment options to patients with severe liver disease.
OncoTAb
OncoTAb's cutting edge blood test aids breast cancer detection in women with dense breast tissue.
Petri
Co-founded with iconic bio entrepreneurs to fund formation-stage bioengineering companies.
Precise Telehealth
Precise Telehealth delivers chronic condition management services to the home via telemedicine.
REMD Biotherapeutics
REMD Biotherapeutics provides medications for chronic illnesses such as metabolic diseases.
Shreveport Aquatic and Land Physical Therapy
Shreveport Aquatic & Land Therapies is changing the way patients experience physical healing.
Visible Genomics
Visible Genomics provides a clinically validated age-related macular degeneration (AMD) risk assessment.
Vivid Microscopy
Vivid Microscopy has generated three probes that can image.
Current Advisors List
Current Employees Featured
Founder
Investors List
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series A - Modis Therapeutics
OrbiMed
OrbiMed investment in Series A - Modis Therapeutics
Aceras Life Sciences
Aceras Life Sciences investment in Series A - Modis Therapeutics
F-Prime Capital
F-Prime Capital investment in Series A - Modis Therapeutics
Official Site Inspections
http://www.modistx.com
- Host name: 217.19.237.54.static.hosted.by.combell.com
- IP address: 217.19.237.54
- Location: Brussels Belgium
- Latitude: 50.8336
- Longitude: 4.3337
- Timezone: Europe/Brussels
- Postal: 1060
More informations about "Modis Therapeutics"
Modis Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1-510-806-8562 Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.See details»
Modis Therapeutics Company Profile 2024: Valuation, …
Operator of a biopharmaceutical company intended to develop disease-modifying therapies for rare genetic diseases with a high unmet medical need.See details»
Home - Modus Therapeutics
Modus is a Swedish biotechnology company that is developing its proprietary polysaccharide sevuparin as a potential treatment for several major healthcare needs including sepsis/septic shock and other disorders with severe systemic …See details»
Zogenix Announces Acquisition of Modis Therapeutics, Inc.
Aug 26, 2019 · Modis’s lead product candidate, MT1621, an investigational deoxynucleoside substrate enhancement therapy, is in late-stage development for the treatment of Thymidine …See details»
Zogenix Announces Acquisition of Modis Therapeutics, Inc.
Zogenix, Inc, a global pharmaceutical company developing rare disease therapies, announced that it has entered into a definitive agreement toSee details»
Zogenix buys Modis for $250M, building out rare disease pipeline
Aug 26, 2019 · Zogenix is expanding its pipeline beyond lead drug Fintepla, saying Monday it will pay $250 million upfront to acquire Modis Therapeutics, a privately-held biotech developing a …See details»
Modis Therapeutics - VentureRadar
Website: http://www.modistx.com/ Develops disease-modifying therapies for rare genetic diseases with high unmet medical needs, focusing on mitochondrial biology and TK2d. VentureRadar …See details»
Zogenix Completes Acquisition of Modis Therapeutics, Inc.
Sep 9, 2019 · MT1621 is a novel investigational deoxynucleoside substrate enhancement therapy for the treatment of Thymidine Kinase 2 deficiency (TK2d), an inherited mitochondrial DNA …See details»
Zogenix Buys Modis in $400 Million-Plus Deal to Make Larger Rare ...
Aug 26, 2019 · Zogenix, based in Emeryville, California, announced it is acquiring Oakland, California-based Modis. Both companies focus on rare diseases. Under the terms of the deal, …See details»
Modis Therapeutics, Inc | CipherBio
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases. Identify leads, gain more opportunities, close more deals. Research top life science investors …See details»
Joshua Grass - CEO at Escient Pharmaceuticals - The Org
As an Entrepreneur in Residence at F-Prime Capital, Josh led a $30M series A financing (F-Prime Capital and Orbimed Advisors) of ModisTx in March of 2018. ModisTx was acquired by …See details»
Modis Therapeutics - Craft
Modis Therapeutics is a biopharmaceutical company that develops disease-modifying therapies for the treatment of genetic diseases. See insights on Modis Therapeutics including office …See details»
Zogenix agrees to buy Modis Therapeutics in $400m deal
Pharmaceutical company Zogenix has signed a definitive agreement to buy Modis Therapeutics in a deal worth approximately $400m, including an upfront payment of $250m. Founded in 2016, …See details»
Zogenix’ Acquisition of Modis Therapeutics Completes
Sep 9, 2019 · Zogenix (NASDAQ:ZGNX) has announced its acquisition of Modis Therapeutics has completed and that it has added MT1621 to its late-stage development pipeline.See details»
Modis Therapeutics, Inc. | Insights
Feb 24, 2019 · Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Joshua Grass - Escient pharmaceuticals
Joshua Grass, Chief Executive Officer, joined Escient in December 2021. Most recently, Josh was Chief Executive Officer from 2017 to 2019 of Modis Therapeutics, a company developing a …See details»
My Account
Access and manage your Microsoft account and organizations.See details»
Organisation vs. Organization: What’s the Difference?
In this article, I’ll compare organisation vs. organization. I’ll use each one in a sentence. Then, I’ll give you a helpful trick to remember whether to use organisation or organization in your …See details»
The Matrix Organization - Project Management Institute
What Is A Matrix Organization? A matrix organization is defined as one in which there is dual or multiple managerial accountability and responsibility. However, the term matrix means quite …See details»
What is a matrix organization and how does it work? - Asana
Feb 22, 2024 · What is a matrix organization and how does it work? A matrix organization is a company structure where teams report to multiple leaders. The matrix design keeps open …See details»